Aortic Dimensions in Turner Syndrome
Aortic Dimensions, 24hour Ambulatory Blood Pressure and Sympathovagal Tone in Turner Syndrome. In Relation to Aortic Dilatation and Dissection.
1 other identifier
observational
102
0 countries
N/A
Brief Summary
An observational study of 102 women with Turner syndrome followed for 6 years with a two-yearly examination including ECHO, MRI of the heart and 24 ambulatory blood pressure. It has been found that besides an significantly increased risk of congenital cardiac malformations, TS have an increased risk of developing cardiac disease including the life threatening condition of aortic dilatation and rupture. The aim of the study is to describe the cardiac conditions of TS, evaluate different methods of examination and identify possible risc factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2003
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2003
CompletedFirst Submitted
Initial submission to the registry
February 19, 2008
CompletedFirst Posted
Study publicly available on registry
February 28, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedFebruary 28, 2008
February 1, 2008
8.8 years
February 19, 2008
February 27, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Aortic diameter at 3 well-defined levels measured by MRI and ECHO
2-yearly for 6 years
Secondary Outcomes (1)
24hour ambulatory blood pressure
24h 2-yearly for 6 years
Study Arms (2)
1
women with Turner syndrome
2.
Control women
Eligibility Criteria
Recrutted from hospital clinics and through the patient organisation
You may qualify if:
- Turner syndrome
- Age 18-70 years
You may not qualify if:
- Extreme adipositas
- Contraindications to a MRI scan
- Malignant disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Viuff M, Skakkebaek A, Johannsen EB, Chang S, Pedersen SB, Lauritsen KM, Pedersen MGB, Trolle C, Just J, Gravholt CH. X chromosome dosage and the genetic impact across human tissues. Genome Med. 2023 Mar 28;15(1):21. doi: 10.1186/s13073-023-01169-4.
PMID: 36978128DERIVEDTrolle C, Mortensen KH, Bjerre M, Hougaard DM, Cohen A, Andersen NH, Gravholt CH. Osteoprotegerin in Turner syndrome - relationship to aortic diameter. Clin Endocrinol (Oxf). 2015 Mar;82(3):397-403. doi: 10.1111/cen.12522. Epub 2014 Jul 2.
PMID: 24923356DERIVEDTrolle C, Mortensen KH, Pedersen LN, Berglund A, Jensen HK, Andersen NH, Gravholt CH. Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations. PLoS One. 2013 Jul 25;8(7):e69614. doi: 10.1371/journal.pone.0069614. Print 2013.
PMID: 23936059DERIVED
Biospecimen
Blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 19, 2008
First Posted
February 28, 2008
Study Start
August 1, 2003
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
February 28, 2008
Record last verified: 2008-02